Pfizer Stock Higher on Multi-Billion Dollar Metsera Buyout

Pfizer Inc (NYSE:PFE) stock is up 2.6% to trade at $24.65 at last check, after the pharma giant revealed it will buy weight-loss drug company Metsera (MTSR) in a deal valued up to $7.3 billion.PFE is on track for its best single-day percentage gain since July as well as its third gain in the last four sessions. A ceiling at the $25 level remains after in late August the stock pulled back form a rally to its highest level since March, however. In the last 12 months, the equity shed 16.5%.Options bulls are ch ...